About Us

Avia Vascular is a medical device manufacture focused on providing more compassionate care with The Ally Device and The Stiletto Device. Through advanced technology, the devices are intended to reduce the need for venipuncture when obtaining blood samples for inpatients and placing extended dwell catheters for those who require frequent infusions. Our primary objective is to provide technology to address the most common, and most invasive procedure to enhance patient experiences, improve outcomes, and reduce cost for providers and hospitals.

Who We Are.

At the core, Avia Vascular is a team of innovators and specialists with a shared desire to solve meaningful problems and improve the quality of healthcare worldwide.  

 Through strategic partnerships and business practices, we are able to leverage business practices to achieve our mission to provide compassionate care, and drive innovation when addressing patient and provider outcomes. We are passionate about our work and dedicated to our mission of developing new technologies exceeding industry expectations.

Our Team

Kevin Cook

CEO

Paul Blackburn, MNA, RN

VP Clinical Development

Dan Higgs

Chief IP Counsel

Michael Pell

Engineering Manager

Chad Nielson

Dir. Quality & Operations

Scott Milligan

National Account Manager

Patrick Eggen, RN

Clinical Manager

Our Investor

Avia Vascular is a subsidiary of MedVenture Health (MVH). MVH partners with entrepreneurs, physicians, and management teams to advance healthcare products, services, and technologies. MVH provides expertise and capital resources to assist in creating value; investing in healthcare companies at a stage in their development where an infusion of capital and strategic assistance will significantly enhance value.